Potent neutralization of SARS-CoV-2 by human antibody heavy-chain variable domains isolated from a large library with a new stable scaffold
Effective therapies are urgently needed for COVID-19. Here we describe the identification of a new stable human immunoglobulin G1 heavy-chain variable (VH) domain scaffold that was used for the construction of a large library, lCAT6, of engineered human VHs. This library was panned against the recep...
Saved in:
Main Authors: | Zehua Sun (Author), Chuan Chen (Author), Wei Li (Author), David R. Martinez (Author), Aleksandra Drelich (Author), Du-San Baek (Author), Xianglei Liu (Author), John W. Mellors (Author), Chien-Te Tseng (Author), Ralph S. Baric (Author), Dimiter S. Dimitrov (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Construction of Novel Bispecific Single-Domain Antibodies (BiSdAbs) with Potent Antiangiogenic Activities
by: Xianglei Liu, et al.
Published: (2020) -
Potent neutralization of SARS‐CoV‐2 including variants of concern by vaccines presenting the receptor‐binding domain multivalently from nanoscaffolds
by: Peter J. Halfmann, et al.
Published: (2021) -
Characterization of neutralizing chimeric heavy-chain antibodies against tetanus toxin
by: Kexuan Cheng, et al.
Published: (2024) -
An engineered human IgG1 CH2 domain with decreased aggregation and nonspecific binding
by: Guangcan Cao, et al.
Published: (2020) -
Discovery of a novel highly specific, fully human PSCA antibody and its application as an antibody-drug conjugate in prostate cancer
by: Xiaojie Chu, et al.
Published: (2024)